F J Rohr
Overview
Explore the profile of F J Rohr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rohr F, Munier A, Levy H
J Inherit Metab Dis
. 2002 Jan;
24(6):623-30.
PMID: 11768582
The major source of protein in the dietary treatment of phenylketonuria(PKU) is a phenylalanine-free amino acid mixture. Traditionally, these medical products have also contained other nutrients and have been in...
2.
Kalsner L, Rohr F, Strauss K, Korson M, Levy H
J Pediatr
. 2001 Sep;
139(3):421-7.
PMID: 11562623
Unlabelled: Tyrosine supplementation has not consistently been found to improve neuropsychologic function in phenylketonuria (PKU), possibly because of failure to achieve adequate levels of tyrosine in the brain. Objectives: To...
3.
ACOSTA P, Matalon K, Castiglioni L, Rohr F, Wenz E, Austin V, et al.
Am J Clin Nutr
. 2001 Mar;
73(4):792-6.
PMID: 11273855
Background: Women with untreated phenylketonuria (PKU) often have poor reproductive outcomes. Objective: We assessed the effects of intakes of major nutrients on plasma phenylalanine concentrations and we measured phenylalanine hydroxylase...
4.
Duran G, Rohr F, Slonim A, Guttler F, Levy H
J Am Diet Assoc
. 1999 Dec;
99(12):1559-63.
PMID: 10608951
The importance of complete or almost complete intake of the recommended amount of phenylalanine-free amino acid mixture (AAM) for control of blood phenylalanine level in patients being treated for phenylketonuria...
5.
Rohr F, Lobbregt D, Levy H
Am J Clin Nutr
. 1998 Mar;
67(3):473-6.
PMID: 9497192
Lower than average concentrations of tyrosine could be a factor in the fetal damage produced by maternal phenylketonuria (PKU). Dietary supplementation with L-tyrosine has been inconsistent in these reported pregnancies....
6.
North K, Korson M, Gopal Y, Rohr F, BRAZELTON T, Waisbren S, et al.
J Pediatr
. 1995 Jun;
126(6):916-22.
PMID: 7539836
Objectives: To document the clinical and neurodevelopmental profiles of a cohort of patients with neonatal-onset propionic acidemia and to determine the efficacy of current therapy with respect to outcome. Method:...
7.
Doherty L, Rohr F, Levy H
Pediatrics
. 1991 Feb;
87(2):240-4.
PMID: 1987536
Early hospital discharge of newborns is leading to collection of the newborn screening blood specimen during the first day of life in increasing numbers of newborns. There is concern that...
8.
Waisbren S, Doherty L, Bailey I, Rohr F, Levy H
Am J Public Health
. 1988 Jul;
78(7):789-92.
PMID: 3381953
Young women with phenylketonuria (PKU) are at risk for bearing children with mental retardation, microcephaly, heart defects, and low birthweight. These effects may be prevented if a low phenylalanine diet...
9.
Rohr F, Doherty L, Waisbren S, Bailey I, Ampola M, Benacerraf B, et al.
J Pediatr
. 1987 Mar;
110(3):391-8.
PMID: 3819940
Four women with classic phenylketonuria (blood phenylalanine greater than 1200 mumol/L) were given a phenylalanine-restricted diet; three also received L-tyrosine supplements. Biochemical measures of nutrition were normal except for iron...
10.
Caballero B, Mahon B, Rohr F, Levy H, Wurtman R
J Pediatr
. 1986 Oct;
109(4):668-71.
PMID: 3761084
No abstract available.